Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userTowards a fully predictive model of flight paths in pigeons navigating in the familiar area: prediction across differing individuals
83
0
0.0
(
0
)
Authors
Richard P. Mann
Ask ChatGPT about the research
No Arabic abstract
This paper will detail the basis of our previously developed predictive model for pigeon flight paths based on observations of the specific individual being predicted. We will then describe how this model can be adapted to predict the flight of a new, unobserved bird, based on observations of other individuals from the same release site. We will test the accuracy of these predictions relative to naive models with no previous flight information and those trained on the focal birds own previous flights, and discuss the implications of these results for the nature of navigational cue use in the familiar area. Finally we will discuss how visual cues may be explicitly encoded in the model in future work.
rate research
Read More
Collective movement can be achieved when individuals respond to the local movements and positions of their neighbours. Some individuals may disproportionately influence group movement if they occupy particular spatial positions in the group, for example, positions at the front of the group. We asked, therefore, what led individuals in moving pairs of fish (Gambusia holbrooki) to occupy a position in front of their partner. Individuals adjusted their speed and direction differently in response to their partners position, resulting in individuals occupying different positions in the group. Individuals that were found most often at the front of the pair had greater mean changes in speed than their partner, and were less likely to turn towards their partner, compared to those individuals most often found at the back of the pair. The pair moved faster when led by the individual that was usually at the front. Our results highlight how differences in the social responsiveness between individuals can give rise to leadership in free moving groups. They also demonstrate how the movement characteristics of groups depend on the spatial configuration of individuals within them.
In this paper, we build a new, simple, and interpretable mathematical model to describe the human glucose-insulin system. Our ultimate goal is the robust control of the blood glucose (BG) level of individuals to a desired healthy range, by means of adjusting the amount of nutrition and/or external insulin appropriately. By constructing a simple yet flexible model class, with interpretable parameters, this general model can be specialized to work in different settings, such as type 2 diabetes mellitus (T2DM) and intensive care unit (ICU); different choices of appropriate model functions describing uptake of nutrition and removal of glucose differentiate between the models. In both cases, the available data is sparse and collected in clinical settings, major factors that have constrained our model choice to the simple form adopted. The model has the form of a linear stochastic differential equation (SDE) to describe the evolution of the BG level. The model includes a term quantifying glucose removal from the bloodstream through the regulation system of the human body, and another two terms representing the effect of nutrition and externally delivered insulin. The parameters entering the equation must be learned in a patient-specific fashion, leading to personalized models. We present numerical results on patient-specific parameter estimation and future BG level forecasting in T2DM and ICU settings. The resulting model leads to the prediction of the BG level as an expected value accompanied by a band around this value which accounts for uncertainties in the prediction. Such predictions, then, have the potential for use as part of control systems which are robust to model imperfections and noisy data. Finally, a comparison of the predictive capability of the model with two different models specifically built for T2DM and ICU contexts is also performed.
COVID-19 clinical presentation and prognosis are highly variable, ranging from asymptomatic and paucisymptomatic cases to acute respiratory distress syndrome and multi-organ involvement. We developed a hybrid machine learning/deep learning model to classify patients in two outcome categories, non-ICU and ICU (intensive care admission or death), using 558 patients admitted in a northern Italy hospital in February/May of 2020. A fully 3D patient-level CNN classifier on baseline CT images is used as feature extractor. Features extracted, alongside with laboratory and clinical data, are fed for selection in a Boruta algorithm with SHAP game theoretical values. A classifier is built on the reduced feature space using CatBoost gradient boosting algorithm and reaching a probabilistic AUC of 0.949 on holdout test set. The model aims to provide clinical decision support to medical doctors, with the probability score of belonging to an outcome class and with case-based SHAP interpretation of features importance.
Precision medicine is becoming a focus in medical research recently, as its implementation brings values to all stakeholders in the healthcare system. Various statistical methodologies have been developed tackling problems in different aspects of this field, e.g., assessing treatment heterogeneity, identifying patient subgroups, or building treatment decision models. However, there is a lack of new tools devoted to selecting and prioritizing predictive biomarkers. We propose a novel tree-based ensemble method, random interaction forest (RIF), to generate predictive importance scores and prioritize candidate biomarkers for constructing refined treatment decision models. RIF was evaluated by comparing with the conventional random forest and univariable regression methods and showed favorable properties under various simulation scenarios. We applied the proposed RIF method to a biomarker dataset from two phase III clinical trials of bezlotoxumab on $textit{Clostridium difficile}$ infection recurrence and obtained biologically meaningful results.
To enable personalized cancer treatment, machine learning models have been developed to predict drug response as a function of tumor and drug features. However, most algorithm development efforts have relied on cross validation within a single study to assess model accuracy. While an essential first step, cross validation within a biological data set typically provides an overly optimistic estimate of the prediction performance on independent test sets. To provide a more rigorous assessment of model generalizability between different studies, we use machine learning to analyze five publicly available cell line-based data sets: NCI60, CTRP, GDSC, CCLE and gCSI. Based on observed experimental variability across studies, we explore estimates of prediction upper bounds. We report performance results of a variety of machine learning models, with a multitasking deep neural network achieving the best cross-study generalizability. By multiple measures, models trained on CTRP yield the most accurate predictions on the remaining testing data, and gCSI is the most predictable among the cell line data sets included in this study. With these experiments and further simulations on partial data, two lessons emerge: (1) differences in viability assays can limit model generalizability across studies, and (2) drug diversity, more than tumor diversity, is crucial for raising model generalizability in preclinical screening.
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
